Onsite FibroScan® • ABIM • ABOM
Your Liver Works in Silence — Until It Can’t.
Liver disease is common, silent, and often missed. Early detection can change the outcome.
Many people with obesity, insulin resistance, diabetes, or high visceral fat are quietly developing fatty liver disease. Because symptoms often don’t appear early, the first sign can be advanced fibrosis or cirrhosis.
At Anti‑Aging & Metabolic Health, we focus on early identification and prevention using FibroScan®, metabolic labs, and a comprehensive obesity‑medicine approach.
Quick Scan Highlights
Designed for early detection, ongoing monitoring, and treatment eligibility decisions.
The Stealth Threat of Liver Disease
Metabolic dysfunction–associated steatohepatitis (MASH) is the most common cause of chronic liver disease today — and most people don’t know they have it.
Without screening, patients may not be diagnosed until advanced liver damage has already occurred.
Experience That Sees Beyond Lab Results
As a board-certified internist and obesity medicine specialist (ABIM, ABOM), Dr. Gonzalez frequently identifies liver disease in patients who feel well and appear healthy.
Our approach is prevention-first: detect risk early, quantify it accurately, and intervene before irreversible damage occurs.
Early warning signs are often subtle:
Breakthrough Treatments for MASH Are Here
For the first time, FDA-approved therapies are available to treat metabolic liver disease.
Eligibility depends on accurate staging of liver fibrosis — making proper screening essential.
Early Detection With Real Data (No Needles)
We combine advanced diagnostics to identify liver disease early — before symptoms appear.
FibroScan® is a fast, noninvasive test performed in-office that provides immediate insight into liver health — no needles, no sedation, and no downtime.
From Diagnosis to Reversal
Once liver disease is identified, we develop a personalized plan focused on reversing inflammation, reducing fibrosis risk, and improving metabolic health.
Many patients experience improvements in liver enzymes, insulin resistance, and FibroScan® scores over time.
Covered When Needed. Affordable When You Choose.
Insurance typically covers initial diagnostic evaluation and treatment when medically indicated.
However, repeat FibroScan® monitoring for prevention or progress tracking is often not covered.
